Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The success of immunotherapy of cancer depends on several cellular events in the tumors that can be visualized by live microscopy strategies in experimental models. Taking advantage of advanced microscopy techniques, Lehmann and colleagues explore in this issue of CCR the mechanism of action of a novel bispecific mAb (TCB-CEA) that targets membrane-bound CEA and CD3ε. Clin Cancer Res; 22(17); 4277-9. ©2016 AACRSee related article by Lehmann et al., p. 4417.

Original publication

DOI

10.1158/1078-0432.ccr-16-1072

Type

Journal article

Journal

Clinical cancer research : an official journal of the American Association for Cancer Research

Publication Date

09/2016

Volume

22

Pages

4277 - 4279

Addresses

Immunology and Immunotherapy Department, CIMA, Pamplona, Spain.

Keywords

Animals, Humans, Neoplasms, Antibodies, Bispecific, Antigens, Neoplasm, Microscopy, Immunotherapy, Biomarkers, Tumor, Antineoplastic Agents, Immunological